Summary

According to a multicenter, prospective registry study, patients with AF can safely undergo radiofrequency catheter ablation while continuing apixaban or rivaroxaban without undergoing prior transesophageal echocardiography. Among patients who did not undergo transesophageal echocardiography, there was no evidence of left atrial appendage thrombosis, and less than half had “smoke” on intracardiac echocardiography.